Your session is about to expire
← Back to Search
mRNA-1273 Vaccine for COVID-19 in Adolescents (TeenCove Trial)
TeenCove Trial Summary
This trial is testing a vaccine to prevent COVID-19. It will study how safe and effective it is in adolescents, and will also study an optional booster dose.
TeenCove Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTeenCove Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 2013 Patients • NCT05047770TeenCove Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I'm sorry, you didn't provide a criterion for me to rewrite. Could you please provide one?Has your child stayed in the United States for the last month without traveling abroad?Your child has not yet received a COVID-19 vaccine.Your child has not been diagnosed with COVID-19 or been in close contact with someone who has had COVID-19 in the last two weeks.Is your child currently healthy?Is your child between 12 and 17 years old?Your child cannot participate if they had a vaccine or were in a clinical trial within the last month.I'm sorry, it looks like you didn't include a criterion for me to summarize. Please provide the criterion you would like me to rewrite.
- Group 1: mRNA-1273
- Group 2: Placebo
- Group 3: mRNA-1273 BD
- Group 4: mRNA-1273.222
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this clinical trial being conducted in multiple locations within the city?
"There are many locations participating in this clinical trial, but a few notable ones are Cottonwood Pediatrics in Hastings, Nebraska, Meridian Clinical Research (Omaha-Nebraska) - Platinum - PPDS in Omaha, South carolina, and Meridian Clinical Research - Charleston, SC in Charleston."
Does this research involve any participants who are octogenarians or younger?
"This study is meant for children aged 12 to 18. Out of the 1,144 total clinical trials, this one falls in the 146 trials catering to those under 18 years old."
Is this research looking for new participants at the moment?
"Unfortunately, this particular study is not currently looking for participants. Although, it's worth noting that the trial was most recently updated on October 25th, 2020. There are 1119 other trials actively recruiting patients with covid-19 and 28 studies for mRNA-1273 that are still looking for volunteers."
What are the requirements for participants in this experiment?
"This clinical trial is recruiting 3931 people with covid-19 aged 12 and 18. Most importantly, applicants should meet the following criteria: • Participants 12 to <18 years of age at the time of consent (Screening Visit, Day 0) who, in the opinion of the Investigator, are in good general health based on review of medical history and screening physical examination., • Investigator assessment that the participant, in the case of an emancipated minor, or parent(s)/legally acceptable representative(s) [LAR(s)] understand and is willing and physically able to comply with protocol-"
How many guinea pigs are a part of this experiment?
"This trial is no longer recruiting patients. It was initially posted on December 9th, 2020 and last updated on October 25th, 2022. However, there are 1119 other trials related to covid-19 that are still admitting participants and 28 mRNA-1273 trials that are also currently enrolling patients."
Is this research project something new?
"Since 2020, mRNA-1273 has undergone extensive clinical trials. The first was sponsored by ModernaTX and took place in the same year. After involving 120 patients, it received Phase 1 approval in 2020. Currently, there are 28 active studies being conducted for this medication across 219 cities and 22 countries worldwide."
Are there other research projects that have used the mRNA-1273 vaccine?
"mRNA-1273 was first trialed in 2020 by the Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases. So far, a total of 18295 completed trials have been conducted. There are presently 28 live clinical trials, with a large number taking place in Hastings, Nebraska."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger